Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2024Frontiers in OncologyOpen Access

The research advances in Kirsten rat sarcoma viral oncogene homolog (KRAS)-related cancer during 2013 to 2022: a scientometric analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YHYujie HuangKaohsiung Chang Gung Memorial HospitalDZDaitian ZhengShantou UniversityZZZhongming ZhouShantou University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huang et al. (2024) studied this question.

synapsesocial.com/papers/68e6e66db6db643587661f2ehttps://doi.org/10.3389/fonc.2024.1345737
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 114,778 citations
  2. 2Targeting KRAS mutant cancers: from druggable therapy to drug resistance2022 · 229 citations
  3. 3Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future2020 · 137 citations
  4. 4Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches2021 · 329 citations
  5. 5Trametinib overcomes KRAS‐G12V–induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR‐mutant lung cancer2021 · 26 citations